Valeant Pharmaceuticals International, Inc., a specialty pharmaceutical company, is expanding through the addition of manufacturing lines and solar array assembly at the company’s Optics Center in Rochester, New York. The company held a ceremony that recognized the expansion and installation of the new manufacturing lines, which will produce the company’s silicone hydrogel contact lens, Bausch + Lomb ULTRA. The solar array, which is currently under construction, will generate and supply electricity through the installation of 3,667 solar panels, helping to reduce the Rochester facility’s carbon footprint by 800 tons of carbon dioxide emissions annually.

Valeant acquired Bausch + Lomb, a make of contact lenses and eye care products, in 2013.

Source: Valeant Pharmaceuticals